Court Allows Novartis to Amend Diovan Patent

January 14, 2013
Novartis AG has won court approval to amend a Singapore patent for its top-selling blood pressure drug, Diovan, bringing it a step closer to fending off moves by a Malaysian unit of Indian drugmaker Ranbaxy to invalidate the patent.
Business Times